Rong-Ce Zhao
Overview
Explore the profile of Rong-Ce Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li S, Mei J, Cheng Y, Li Q, Wang Q, Fang C, et al.
J Clin Oncol
. 2022 Dec;
41(10):1898-1908.
PMID: 36525610
Purpose: To report the efficacy and safety of postoperative adjuvant hepatic arterial infusion chemotherapy (HAIC) with 5-fluorouracil and oxaliplatin (FOLFOX) in hepatocellular carcinoma (HCC) patients with microvascular invasion (MVI). Patients...
2.
Deng M, Lin J, Zhao R, Li S, Lin W, Zou J, et al.
BMC Cancer
. 2021 Dec;
21(1):1347.
PMID: 34923955
Background: The accuracy of existing biomarkers for predicting the prognosis of hepatocellular carcinoma (HCC) is not satisfactory. It is necessary to explore biomarkers that can accurately predict the prognosis of...
3.
Deng M, Fang L, Li S, Zhao R, Mei J, Zou J, et al.
Mutagenesis
. 2021 Sep;
36(5):369-379.
PMID: 34467992
Hepatocellular carcinoma (HCC) is still one of the most common malignancies worldwide. The accuracy of biomarkers for predicting the prognosis of HCC and the therapeutic effect is not satisfactory. N6-methyladenosine...
4.
Huang Y, Wei L, Zhao R, Liang W, Zhang J, Ding X, et al.
J Cancer
. 2018 Jun;
9(12):2203-2210.
PMID: 29937940
Most hepatocellular carcinoma (HCC) patients have undergone a progression from chronic hepatitis, then liver cirrhosis (LC), and finally to carcinoma. The objective of this study was to elucidate risk factors...
5.
Zhao R, Zhou J, Wei Y, Liu F, Chen K, Li Q, et al.
Hepatobiliary Pancreat Dis Int
. 2017 Oct;
16(5):493-498.
PMID: 28992881
Background: Transcatheter arterial chemoembolization (TACE) and TACE in combination with sorafenib (TACE-sorafenib) have shown a significant survival benefit for the treatment of unresectable hepatocellular carcinoma (HCC). Adopting either as a...
6.
Huang Y, Wei L, Sun A, Zhao R, Zhang J, Yang H, et al.
Sichuan Da Xue Xue Bao Yi Xue Ban
. 2017 Jun;
47(6):883-888.
PMID: 28598118
Objectives: To investigate the relationship between aberrant promoter CpG islands methylation status of secreted frizzled related protein 1 (SFRP1) and long intersper sed nuclear element 1 () gene and clinicopathologic...
7.
Zhao R, Zhou J, He J, Wei Y, Qin Y, Li B
J BUON
. 2016 Apr;
21(1):142-51.
PMID: 27061542
Purpose: We conducted this meta-analysis of published case-control studies aiming to evaluate the relationship between abnormal suppression of cytokine signaling-1 (SOCS-1) promoter methylation and the risk of hepatocellular carcinoma (HCC)....
8.
Yu X, Wei L, Liu Q, Huang Y, Zhao R, Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban
. 2015 Dec;
46(5):661-6.
PMID: 26619531
Objective: To investigate the mechanisms of interaction between high-density lipoprotein binding protein (HDLBP)-VIGILIN with other proteins, we cloned VIGILIN cDNA N, KH1-7, KH8-12, KH13-14, and C fragments separately into expression...